Igenbio

Igenbio is a private, revenue-generating company founded in 2015, operating at the intersection of genomics services and bioinformatics software. Its core offering is the ERGO platform, an integrated cloud-based system for genome analysis, annotation, and metabolic reconstruction, complemented by a suite of expert genomic sequencing services. The company leverages decades of scientific expertise to serve a global clientele, including Fortune 500 companies and leading research institutions, primarily in the industrial biotechnology and life sciences sectors. Its business model is a hybrid of a SaaS platform (ERGO) and fee-for-service contract research.

ERGO™, a cloud-based integrated informatics platform combining a curated genomic database with tools for genome annotation, metabolic reconstruction, microbiome analysis, differential expression, and variant analysis.

Igenbio competes in a fragmented market against large sequencing service providers (e.g., Eurofins, Azenta), bioinformatics software firms (e.g., DNAnexus, Partek), and open-source tools. Its differentiation lies in the integration of its curated database with analysis tools specifically tailored for industrial metabolic engineering and microbiome applications.